Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Roche / Genentech (Internal Manufacturing & CustomBiotech)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Basel, Switzerland
- Modalities
- Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Roche / Genentech (Internal Manufacturing & CustomBiotech)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
Genentech eliminates 87 jobs in another round of South San Francisco layoffs - Fierce Biotech
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge - BioSpace
Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California - European Biotechnology Magazine
Recursion Reports First Quarter Financial Results and Provides Business Update - The Manila Times
Genentech dials up more Holly Springs growth - Business North Carolina
Swiss drugmaker surges Wake County investment to $2 billion, 500 jobs - The Business Journals
Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma
Roche Launches New ‘AI Factory’ To Speed Drug Development - Forbes
Genentech Expands RNAi Pipeline Through Global Licensing Deal - BioPharm International
AI Fuels Genentech’s R&D Ecosystem - Genentech
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics
Lonza
Basel, Switzerland
Signal Score: 78.2
AAV, Lentiviral, Cell Therapy, mRNA
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA